Edwards THV Virtual Learning Portal – Transcatheter Heart Valves Virtual Learning Portal

Welcome to the Structural Heart Transcatheter Therapy Virtual Learning Portal

In our learning portal, you will be able to gain access to a range of webinars, resources and events to keep your knowledge current for your structural heart patients.

Structural Heart Disease & Transcatheter Therapy educational resources
led by experienced subject-matter experts

Engage in learning

Check out our latest content: Log in or Register to MEDD.com.au to view the below content pieces on-demand.

The Next Cardiac Epidemic 3-Part Webinar Series

Bicuspid TAVI and Circle Method SAPIEN 3 Webinar Series

Patients. Our Mission for Life.

Edwards’ extensive professional training and development programmes support patient safety and quality of care by:

Providing extensive training on disease state, therapy, and clinical skills
Providing educational content led by local and international subject-matter experts on the latest evidence on structural heart disease and transcatheter therapies
Helping our clinician partners build a sustainable structural heart program

Clinical education channel

Watch our latest presentations, clinical refreshers and instructional videos for your Structural Heart Disease patients.

We have a variety of topics uploaded to the medical education hosting platform, www.medd.com.au. Simply register as a Health Care Professional
and be verified within 24 hours.

About Edwards Lifesciences

Edwards Lifesciences’ roots date to 1958, when Miles “Lowell” Edwards set out to build the first artificial heart.

Edwards was a 60-year-old, recently retired engineer holding 63 patents in an array of industries, with an entrepreneurial spirit and a dream of helping patients with heart disease.

Our Credo

At Edwards Lifesciences, we are dedicated to providing innovative solutions for people fighting cardiovascular disease.

At Edwards, we partner with physicians to innovate products designed to help patients live longer, healthier and more productive lives. We focus on medical technologies that address large and growing patient populations in which there are significant unmet clinical needs.